QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text PDF Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Articles Ahead of Print [Order Reprint] Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lexchin, J. R Search for Related Content PubMed PubMed Citation Articles by Lexchin, J. R

Implications of Pharmaceutical Industry Funding on Clinical Research

Associate Professor, School of Health Policy and Management, York University; Emergency Department, University Health Network; Associate Professor, Department of Family and Community Medicine, University of Toronto, 121 Walmer Rd., Toronto, Ontario M5R 2X8, Canada, fax 416/736-5227, jlexchin{at}yorku.ca

Reprints: Dr. Lexchin

This commentary explores the influence of industry funding and offers suggestions for overcoming some of the problems. First, it is difficult to obtain funding from some sources for research with limited commercial value. Second, lack of communication among researchers can impede scientific progress. Stopping research before meaningful results are available is another area of concern. Next, suppressed or delayed publication of data may bias the results of meta-analyses, resulting in incorrect risk–benefit profiles for drugs. Finally, commercially funded clinical research is more likely to yield positive results than when funding comes from other sources. Possible solutions are explored.

Published Online, October 23, 2004. www.theannals.com, DOI 10.1345/aph.1E224

This article has been cited by other articles:

				M Doucet and S Sismondo Evaluating solutions to sponsorship bias J. Med. Ethics, August 1, 2008; 34(8): 627 - 630. [Abstract] [Full Text] [PDF]

				J. Goven Processes of Inclusion, Cultures of Calculation, Structures of Power: Scientific Citizenship and the Royal Commission on Genetic Modification Science Technology Human Values, September 1, 2006; 31(5): 565 - 598. [Abstract] [PDF]

				S. E. Nissen and President, American College of Cardiology President's Page: American College of Cardiology Fellowship: Where Ideals and Personal Responsibility Intersect J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1901 - 1903. [Full Text] [PDF]